163 related articles for article (PubMed ID: 27701385)
1. A prognostic profile of hypoxia-induced genes for localised high-grade soft tissue sarcoma.
Aggerholm-Pedersen N; Sørensen BS; Overgaard J; Toustrup K; Baerentzen S; Nielsen OS; Maretty-Kongstad K; Nordsmark M; Alsner J; Safwat A
Br J Cancer; 2016 Oct; 115(9):1096-1104. PubMed ID: 27701385
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in soft tissue sarcoma.
Maretty-Nielsen K
Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
[TBL] [Abstract][Full Text] [Related]
4. The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma.
Bertucci F; De Nonneville A; Finetti P; Perrot D; Nilbert M; Italiano A; Le Cesne A; Skubitz KM; Blay JY; Birnbaum D
Ann Oncol; 2018 Feb; 29(2):459-465. PubMed ID: 29069276
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of XTP1/DEPDC1B and SDP35/DEPDC1A in high grade soft-tissue sarcomas.
Pollino S; Benassi MS; Pazzaglia L; Conti A; Bertani N; Righi A; Piccinni-Leopardi M; Picci P; Perris R
Histol Histopathol; 2018 Jun; 33(6):597-608. PubMed ID: 29297565
[TBL] [Abstract][Full Text] [Related]
6. Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma.
Forker LJ; Bibby B; Yang L; Lane B; Irlam J; Mistry H; Khan M; Valentine H; Wylie J; Shenjere P; Leahy M; Gaunt P; Billingham L; Seddon BM; Grimer R; Robinson M; Choudhury A; West C
Br J Cancer; 2023 Jun; 128(12):2307-2317. PubMed ID: 37085598
[TBL] [Abstract][Full Text] [Related]
7. A three-gene signature for outcome in soft tissue sarcoma.
Hoffmann AC; Danenberg KD; Taubert H; Danenberg PV; Wuerl P
Clin Cancer Res; 2009 Aug; 15(16):5191-8. PubMed ID: 19671876
[TBL] [Abstract][Full Text] [Related]
8. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
9. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
10. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
Medicine (Baltimore); 2015 Jul; 94(28):e1142. PubMed ID: 26181552
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma.
Andreou D; Werner M; Pink D; Traub F; Schuler M; Gosheger G; Jobke B; Reichardt P; Tunn PU
Br J Cancer; 2015 Feb; 112(3):455-60. PubMed ID: 25535732
[TBL] [Abstract][Full Text] [Related]
12. Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG.
Grünwald V; Litière S; Young R; Messiou C; Lia M; Wardelmann E; van der Graaf W; Gronchi A; Judson I;
Eur J Cancer; 2016 Sep; 64():44-51. PubMed ID: 27323349
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of newer prognostic markers for adult soft tissue sarcomas.
Levine EA; Holzmayer T; Bacus S; Mechetner E; Mera R; Bolliger C; Roninson IB; Das Gupta TK
J Clin Oncol; 1997 Oct; 15(10):3249-57. PubMed ID: 9336362
[TBL] [Abstract][Full Text] [Related]
14. Analysis of gene expression profiles of soft tissue sarcoma using a combination of knowledge-based filtering with integration of multiple statistics.
Takahashi A; Nakayama R; Ishibashi N; Doi A; Ichinohe R; Ikuyo Y; Takahashi T; Marui S; Yasuhara K; Nakamura T; Sugita S; Sakamoto H; Yoshida T; Hasegawa T; Takahashi H
PLoS One; 2014; 9(9):e106801. PubMed ID: 25188299
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations.
Nordsmark M; Alsner J; Keller J; Nielsen OS; Jensen OM; Horsman MR; Overgaard J
Br J Cancer; 2001 Apr; 84(8):1070-5. PubMed ID: 11308256
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer.
Winther M; Alsner J; Tramm T; Nordsmark M
Acta Oncol; 2013 Oct; 52(7):1327-35. PubMed ID: 23957682
[TBL] [Abstract][Full Text] [Related]
17. Expression of HER2/neu does not correlate with survival in soft tissue sarcoma.
Sato T; Peiper M; Heinecke A; Zurakowski D; Eisenberger CF; Hosch S; Knoefel WT; Izbicki JR
Onkologie; 2003 Jun; 26(3):268-71. PubMed ID: 12845212
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
Kim C; Kim EK; Jung H; Chon HJ; Han JW; Shin KH; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Ahn JB; Chung HC; Noh SH; Rha SY; Kim SH; Kim HS
BMC Cancer; 2016 Jul; 16():434. PubMed ID: 27393385
[TBL] [Abstract][Full Text] [Related]
19. Favorable outcome after complete resection in elderly soft tissue sarcoma patients: Japanese Musculoskeletal Oncology Group study.
Yoneda Y; Kunisada T; Naka N; Nishida Y; Kawai A; Morii T; Takeda K; Hasei J; Yamakawa Y; Ozaki T;
Eur J Surg Oncol; 2014 Jan; 40(1):49-54. PubMed ID: 24075825
[TBL] [Abstract][Full Text] [Related]
20. High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patients.
Kehlen A; Greither T; Wach S; Nolte E; Kappler M; Bache M; Holzhausen HJ; Lautenschläger C; Göbel S; Würl P; Immel UD; Agaimy A; Wullich B; Taubert H
Int J Cancer; 2014 Nov; 135(9):2096-106. PubMed ID: 24676787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]